PUEROVITA BIOTECHNOLOGY

ACCESS TO EXTENDED LIFE – FOR ALL

About Us

We are a cross-disciplinary team passionate about driving change and disruption to the fundamentals of health – scientists at heart, and business people with a heart. We’re at the forefront of cutting-edge biotechnology, harnessing the power of multi-omics and patient data to create innovative solutions that empower health professionals.

Agespan, our flagship product, is a state-of-the-art medical platform that leverages the latest advancements in genomics, epigenetic, and artificial intelligence. Designed for healthcare professionals, Agespan offers precise disease risk predictions, personalized health recommendations, and tailored treatment insights. By analyzing omic data, lifestyle factors, and medical history, Agespan empowers healthcare providers to offer individualized care that can lead to early disease prevention and improved patient outcomes. With Agespan, the future of healthcare is personal, data-driven, and more effective.

Our mission is to revolutionize healthcare by providing professionals and individuals with the tools they need to proactively manage their health, prevent disease, and make data-driven decisions.

Join us on a journey towards a healthier, more personalized future.

|

“Aging is not in itself a disease, but a normal process that sets an upper limit to how long we live”

PueroVita will change that

Aging is the most significant cause for cancer, Alzheimer and diabetes.

We are changing life at age from being alive to living. By using never seen before information about your specific biology – we help you make intelligent health decisions.

Your access to a long, healthy life – based on science.

PueroVita provides easy access to a long, healthy, life through precise, updated personalized information, tools and products- for individuals, GP’s, clinics and scientists.

“Finally someone is looking to go from research to commercial application on this important topic. My team and I are looking forward to the collaboration and development of this initiative”

Evandro Fei Fang

Assistant Professor, UiO
Head of Anti Aging Lab

Team

Valentin A. Normand

Valentin A. Normand

CEO/CSO

PhD Neuroscience

Valentin did his PhD in Neuroscience at the Kavli Institute for System Neuroscience and conducted research in the Moser Lab. He has a strong background both in biology and mathematical modeling. He is responsible for steering the company’s overall strategy, day-to-day operations, and scientific direction.

Alise D. Midtfjord

Alise D. Midtfjord

AI Team Lead

PhD AI / Machine Learning

With a PhD in Trustworthy AI and a background in medical physics, Alise is behind the AI rending our predictions possible. She is developing innovative algorithms to predict risks of complexe diseases by integrating multi-omics data together, with a special focus on uncertainty and explainability.

Irantzu Anzar

Irantzu Anzar

Senior Bioinformatician

PhD in Bioinformatics

Irantzu holds a PhD degree in bioinformatic from University of Oslo. Irantzu has a strong background in personalized immunotherapy and more than 9 years of commercial experience developing bioinformatic pipelines for NGS data analysis. She is behind our bioinformatics core, curating the data required for AI models

Severin Elvatun

Severin Elvatun

AI Engineer

PhD Machine Learning 

During his PhD, Severin worked on developing data-driven algorithms for personalized cancer risk prediction. Later, he transitioned into biomedical applications of Generative AI and Federated Learning. His expertise includes data analytics, AI engineering and software development.

David Volent Lindberg

David Volent Lindberg

Chief Technology officer

PhD Statistics / Mathematics

David did his PhD in Statistics at NTNU. He is the former AI lead in thhe research department of DNV GL, and a Senior AI consultant. David focuses on data security, platform development and quality statistics associated with our predictions.

Akos Buzinkay

Akos Buzinkay

Head of Data Platform

Senior Solution Architect
Akos has more than 25 years of experience in computer science, platform development and applications’ infrastructures. He is responsible of the underlying architecture of our product, building a solid software able to handle big data, fast computing pace, and supporting a user friendly front-end.

Our advisors

Hilde Grønningsæter

Hilde Grønningsæter

Associate Professor, USN

PhD Health & Sport science.

Hilde is the founder of Humentor AS, a company screening and analysing biomarkers for health and job stress, with the goal of increasing health quality and productivity in individuals and organisations.

Rune Ougland

Rune Ougland

Urologist surgeon and resercher

MD, PhD

Konstantinos Palikaras

Konstantinos Palikaras

A.Prof - University of Athens

PhD Molecular Biology

Molecular biologist working with energy metabolism, autophagy and ageing. He obtained the ERC starting grant in 2022 to pursue his groundbreaking research.

Hilde Loge Nilsen

Hilde Loge Nilsen

Professor UiO

PhD Molecular Biology

HIlde’s research focuses, among other things, on the quality control mechanisms that maintain function of DNA and RNA during aging and throughout the lifetime of cells and organisms.

Ingvild Myhre

Ingvild Myhre

iStyrelsen - CEO

Former CEO of Telenor Norge and board member of many companies, Hilde has a great experience in company development and management, and supports our team on these domains.

Board of directors

Inge Grini

Inge Grini

Chairman

With more than 30 years of experience from Entrepreneurship, developing and commecialising advanced tech solutions and leadership withn AI & Analytics, Inge is supporting PueroVita in its overall development, marketing and growth, by leading our board.

Jan-Olav Styrvold

Jan-Olav Styrvold

Board Member

Jan Olav sits in the board of several esablished companies and start-ups, and has strong experience in analytic leadership. He is the chairman of Digital Insight, a business angel network helping PueroVita Biotechnology on its path to success.

Kjersti Koller

Kjersti Koller

Board Member

A seasoned leader with a 30-year record in healthcare, merging economic objectives with employee engagement and sound medical practices. A former CEO of health industry Kjersti’s experience spans negotiation, marketing, business planning, strategy, sales and influencing the pharmacy sector.

David Lindberg

David Lindberg

Board Member

Aside from his involvement in the scientific development of our product, and acting CTO, David also represents Intellectual Labs AS in our board.

Your future long-lived health starts here

PueroVita Biotechnology creates personally and tailored deep insights into your very own biology to make you understand how you are aging and what you can do about it.

Because it is not the same for all people